About Function Oncology
Function Oncology is a Healthcare company based in San Diego (United States) founded in 2018 by Christian Schmedt. It operates as a cancer therapeutics are developed using a CRISPR-enabled platform. Function Oncology has raised $28 million across 1 funding round from investors including ARE, Andreessen Horowitz and Casdin Capital. The company has 16 employees. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is FUNCTION ONCOLOGY INC. Its competitors include Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Function Oncology was founded in 2018 and is headquartered in San Diego, United States. Cancer therapeutics are developed by the company within the biotechnology sector. A CRISPR-enabled platform is utilized to analyze cancer mechanisms and create targeted therapies. Operations focus on advancing precision oncology treatments for various cancer types.
- Headquarters San Diego, United States
- Employees 16
- Founders Christian Schmedt
- SectorsHealthcare
- Email••••••••
- Website functiononcology.com
- Social LinkedIn
- Legal Name Function Oncology Inc
- Total Equity Funding$28M (USD)
in 1 rounds
- Latest Funding Round$28M (USD), Series A
Apr 2023
- InvestorsARE
& 3 more
- Employee Count16
Funding Insights of Function Oncology
Function Oncology has successfully raised a total of $28M through 1 strategic funding round. The most recent funding activity was a Series A round of $28 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28M
- Total Rounds 1
- Last Round Series A — $28M
- First Round $28M
(Apr 2023)
- Investors Count 4
All 1 funding rounds of Function Oncology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Function Oncology
Function Oncology has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Andreessen Horowitz and Casdin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | – | a16z.com | - | |
Investing in Life Sciences sectors like Healthcare and Biotechnology. | – | casdincapital.com | - | |
Tech startups are funded by S32, a venture capital entity. | – | s32.com | Sunnyvale, United States | |
REIT that invests in campuses, multi-tenant spaces and build-to-suit facilities in the US | 1994 | are.com | Pasadena, United States |
Investor details for Function Oncology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Function Oncology
1 people are tracked at Function Oncology (1 in leadership); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Christian Schmedt | Co-Founder | Leadership |
Complete people profiles for Function Oncology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Function Oncology
2 dated milestones of Function Oncology across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Function Oncology is founded.
- Funding First funding round of $28.0M.
Competitors of Function Oncology
Function Oncology has 9 listed competitors in our database, 8 of them funded. They include Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| unitybiotechnology.com | 2016 | San Francisco, United States | $206M | – | Therapeutics for aging diseases are developed by targeting senescent cells. | |
| unilabs.com | 2000 | Geneva, Switzerland | – | – | Diagnostic services are provided through laboratories and radiology units. | |
| celsiustx.com | 2018 | Cambridge, United States | $148M | 50 | Single-cell RNA and genomic analysis for precision therapeutics are provided. | |
| intelliatx.com | 2014 | Cambridge, United States | $85.02M | 526 | Therapeutics using CRISPR/Cas9 are developed for various diseases. |
Detailed competitors of Function Oncology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Function Oncology (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Function Oncology
Complete news archive for Function Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Function Oncology
Function Oncology was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Function Oncology is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Function Oncology is a funded company, having raised a total of $28M across 1 funding round to date. The company's 1st funding round was a Series A of $28M, raised on Apr 2023.
Function Oncology has 16 employees.
Function Oncology was founded in 2018 and is headquartered in San Diego, United States. Cancer therapeutics are developed by the company within the biotechnology sector. A CRISPR-enabled platform is utilized to analyze cancer mechanisms and create targeted therapies. Operations focus on advancing precision oncology treatments for various cancer types.
Function Oncology's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
Function Oncology has 4 investors. Key investors include ARE, Andreessen Horowitz, Casdin Capital, and S32.
Function Oncology operates through Function Oncology Inc.